Pacific Biosciences Of California (PACB) EBT Margin Growth (3y) (2013 - 2026)
Pacific Biosciences Of California (PACB) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 423.00 |
| 10 | Pacific Biosciences Of California | 419.38 Mn | 182.51 Mn | 12.64 Mn | 3,224.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,224.00 |
| Mar 31, 2026 | 20,450.00 |
| Dec 31, 2025 | 21,853.00 |
| Sep 30, 2025 | 14,036.00 |
| Jun 30, 2025 | 9,594.00 |
| Mar 31, 2025 | -90,195.00 |
| Dec 31, 2024 | 19,607.00 |
| Jun 30, 2024 | -19,317.00 |
| Mar 31, 2024 | -7,027.00 |
| Dec 31, 2023 | -41,792.00 |
| Sep 30, 2023 | -1,505.00 |
| Jun 30, 2023 | 32,854.00 |
| Mar 31, 2023 | -1,059.00 |
| Dec 31, 2022 | -23,900.00 |
| Sep 30, 2022 | -10,690.00 |
| Jun 30, 2022 | -9,966.00 |
| Mar 31, 2022 | -5,126.00 |
| Dec 31, 2021 | -2,917.00 |
| Jun 30, 2021 | -15,263.00 |
| Mar 31, 2021 | 19,509.00 |